# DIAGNOSIS of PULMONARY TUBERCULOSIS Through HUMAN BREATH (TBENOSE)

> **NCT04682990** · NA · COMPLETED · sponsor: **University of Rome Tor Vergata** · enrollment: 130 (actual)

## Conditions studied

- Tuberculosis, Pulmonary
- HIV Seropositivity

## Interventions

- **DEVICE:** Tor Vergata Electronic Nose (TV eNose)
- **OTHER:** Survey & Physical Exam
- **DIAGNOSTIC_TEST:** TB LAMP test
- **OTHER:** Sputum Samples
- **OTHER:** Chest X-Ray
- **OTHER:** Follow Up 5 days after beginning of Tx.
- **OTHER:** Follow Up & 15 days after beginning of Tx.
- **OTHER:** Follow Up & 30 days after beginning of Tx.

## Key facts

- **NCT ID:** NCT04682990
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-05
- **Primary completion:** 2021-12-05
- **Final completion:** 2021-12-05
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2021-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04682990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04682990, "DIAGNOSIS of PULMONARY TUBERCULOSIS Through HUMAN BREATH (TBENOSE)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04682990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*